Cortical superficial siderosis and recurrent intracerebral hemorrhage risk in cerebral amyloid angiopathy: Large prospective cohort and preliminary meta-analysis

Abstract

Background

We aimed to investigate cortical superficial siderosis as an MRI predictor of lobar intracerebral hemorrhage (ICH) recurrence risk in cerebral amyloid angiopathy (CAA), in a large prospective MRI cohort and a systematic review.

Methods

We analyzed a single-center MRI prospective cohort of consecutive CAA-related ICH survivors. Using Kaplan–Meier and Cox regression analyses, we investigated cortical superficial siderosis and ICH risk, adjusting for known confounders. We pooled data with eligible published cohorts in a two-stage meta-analysis using random effects models. Covariate-adjusted hazard rations (adj-HR) from pre-specified multivariable Cox proportional hazard models were used.

Results

The cohort included 240 CAA-ICH survivors (cortical superficial siderosis prevalence: 36%). During a median follow-up of 2.6 years (IQR: 0.9–5.1 years) recurrent ICH occurred in 58 patients (24%). In prespecified multivariable Cox regression models, cortical superficial siderosis presence and disseminated cortical superficial siderosis were independent predictors of increased symptomatic ICH risk at follow-up (HR: 2.26; 95% CI: 1.31–3.87, p = 0.003 and HR: 3.59; 95% CI: 1.96–6.57, p < 0.0001, respectively). Three cohorts including 443 CAA-ICH patients in total were eligible for meta-analysis. During a mean follow-up of 2.5 years (range: 2–3 years) 92 patients experienced recurrent ICH (pooled risk ratio: 6.9% per year, 95% CI: 4.2%–9.7% per year). In adjusted pooled analysis, any cortical superficial siderosis and disseminated cortical superficial siderosis were the only independent predictors associated with increased lobar ICH recurrence risk (adj-HR: 2.4; 95% CI: 1.5–3.7; p < 0.0001, and adj-HR: 4.4; 95% CI: 2–9.9; p < 0.0001, respectively).

Conclusions

In CAA-ICH patients, cortical superficial siderosis presence and extent are the most important MRI prognostic risk factors for lobar ICH recurrence. These results can help guide clinical decision making in patients with CAA.

Keywords

Intracerebral hemorrhage MRI cerebral amyloid angiopathy cerebral small vessel disease cortical superficial siderosis

Get full access to this article

View all access options for this article.

References

Charidimou

Boulouis

Gurol

, et al. Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 2017; 140: 1829–1850.

Greenberg

Salman

Biessels

, et al. Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol 2014; 13: 419–428.

Charidimou

Linn

Vernooij

, et al. Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions. Brain 2015; 138: 2126–2139.

Linn

Herms

Dichgans

, et al. Subarachnoid hemosiderosis and superficial cortical hemosiderosis in cerebral amyloid angiopathy. AJNR Am J Neuroradiol 2008; 29: 184–186.

Linn

Wollenweber

Lummel

, et al. Superficial siderosis is a warning sign for future intracranial hemorrhage. J Neurol 2013; 260: 176–181.

Charidimou

Peeters

Jager

, et al. Cortical superficial siderosis and intracerebral hemorrhage risk in cerebral amyloid angiopathy. Neurology 2013; 81: 1666–1673.

Roongpiboonsopit

Charidimou

William

, et al. Cortical superficial siderosis predicts early recurrent lobar hemorrhage. Neurology 2016; 87: 1863–1870.

Wardlaw

Smith

Biessels

, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12: 822–838.

Knudsen

Rosand

Karluk

, et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology 2001; 56: 537–539.

10.

Auriel

Gurol

Ayres

, et al. Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology 2012; 79: 2335–2341.

11.

O'Donnell

Rosand

Knudsen

, et al. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. New Engl J Med 2000; 342: 240–245.

12.

van Etten

Auriel

Haley

, et al. Incidence of symptomatic hemorrhage in patients with lobar microbleeds. Stroke 2014; 45: 2280–2285.

13.

Greenberg

Vernooij

Cordonnier

, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009; 8: 165–174.

14.

Gregoire

Chaudhary

Brown

, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009; 73: 1759–1766.

15.

Linn

Halpin

Demaerel

, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology 2010; 74: 1346–1350.

16.

Charidimou

Jager

Fox

, et al. Prevalence and mechanisms of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology 2013; 81: 626–632.

17.

Greenberg

Eng

Ning

, et al. Hemorrhage burden predicts recurrent intracerebral hemorrhage after lobar hemorrhage. Stroke 2004; 35: 1415–1420.

18.

Biffi

Halpin

Towfighi

, et al. Aspirin and recurrent intracerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2010; 75: 693–698.

19.

Moher

Liberati

Tetzlaff

, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009; 339: b2535.

20.

Stroup

Berlin

Morton

, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008–2012.

21.

von Elm

Altman

Egger

, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453–1457.

22.

DerSimonian

Laird

. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.

23.

Charidimou

Boulouis

Roongpiboonsopit

, et al. Cortical superficial siderosis multifocality in cerebral amyloid angiopathy: a prospective study. Neurology 2017; 89: 2128–2135.

24.

Charidimou

Imaizumi

Moulin

, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: A meta-analysis. Neurology 2017; 89: 820–829.

25.

Charidimou

Jager HR . Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? Lancet Neurol 2014; 13: 538–540.

26.

Koo

Yeon

, et al. Clinical features of high-degree centrum semiovale-perivascular spaces in cerebral amyloid angiopathy. J Neurol Sci 2016; 367: 89–94.

27.

Charidimou

Boulouis

Xiong

, et al. Cortical superficial siderosis and first-ever cerebral hemorrhage in cerebral amyloid angiopathy. Neurology 2017; 88: 1607–1614.

28.

Takeda

Hinokuma

Yamazaki

, et al. The hemorrhage caused by sporadic-type cerebral amyloid angiopathy occurs primarily in the cerebral sulci. Neuropathology 2012; 32: 38–43.

29.

Takeda

Yamazaki

Miyakawa

, et al.

Subcortical hematoma caused by cerebral amyloid angiopathy: does the first evidence of hemorrhage occur in the subarachnoid space?

Neuropathology 2003; 23: 254–261.

30.

Greenberg

Vonsattel

Stakes

, et al. The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993; 43: 2073–2079.

31.

Maia

Mackenzie

Feldman

. Clinical phenotypes of cerebral amyloid angiopathy. J Neurol Sci 2007; 257: 23–30.

32.

Charidimou

. Convexity subarachnoid hemorrhage in cerebral amyloid angiopathy: the saga continues. J Cereb Blood Flow Metab 2015; 35: 707–709.